BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33406428)

  • 1. Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3.
    Sun Y; Zhou Y; Shi Y; Zhang Y; Liu K; Liang R; Sun P; Chang X; Tang W; Zhang Y; Li J; Wang S; Zhu Y; Han X
    Cell Rep; 2021 Jan; 34(1):108576. PubMed ID: 33406428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
    Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
    Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice.
    Qian B; Yang Y; Tang N; Wang J; Sun P; Yang N; Chen F; Wu T; Sun T; Li Y; Chang X; Zhu Y; Zhang Y; Han X
    Diabetologia; 2021 Sep; 64(9):2037-2051. PubMed ID: 34117507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Cell miRNA-503-5p Induced by Hypomethylation and Inflammation Promotes Insulin Resistance and β-Cell Decompensation.
    Zhou Y; Liu K; Tang W; Zhang Y; Sun Y; Wu Y; Shi Y; Yao Z; Li Y; Bai R; Liang R; Sun P; Chang X; Wang S; Zhu Y; Han X
    Diabetes; 2024 Jan; 73(1):57-74. PubMed ID: 37847900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function.
    Xu H; Du X; Xu J; Zhang Y; Tian Y; Liu G; Wang X; Ma M; Du W; Liu Y; Dai L; Huang W; Tong N; Wei Y; Fu X
    PLoS Biol; 2020 Feb; 18(2):e3000603. PubMed ID: 32092075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
    Zhang M; Zhou Z; Wang J; Li S
    Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-322-TRAF3 circuit mediates the pro-apoptotic effect of high glucose on neural stem cells.
    Gu H; Yu J; Dong D; Zhou Q; Wang JY; Yang P
    Toxicol Sci; 2015 Mar; 144(1):186-96. PubMed ID: 25516495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ageing potentiates diet-induced glucose intolerance, β-cell failure and tissue inflammation through TLR4.
    He W; Yuan T; Choezom D; Hunkler H; Annamalai K; Lupse B; Maedler K
    Sci Rep; 2018 Feb; 8(1):2767. PubMed ID: 29426925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.
    Chen Z; Shen H; Sun C; Yin L; Tang F; Zheng P; Liu Y; Brink R; Rui L
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E460-9. PubMed ID: 25628422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte.
    Wu J; Dong T; Chen T; Sun J; Luo J; He J; Wei L; Zeng B; Zhang H; Li W; Liu J; Chen X; Su M; Ni Y; Jiang Q; Zhang Y; Xi Q
    Metabolism; 2020 Feb; 103():154006. PubMed ID: 31715176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-495 regulates macrophage M1/M2 polarization and insulin resistance in high-fat diet-fed mice via targeting FTO.
    Hu F; Tong J; Deng B; Zheng J; Lu C
    Pflugers Arch; 2019 Dec; 471(11-12):1529-1537. PubMed ID: 31709454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of Tonsil-Derived Mesenchymal Stem Cells Improves Glucose Tolerance in High Fat Diet-Induced Diabetic Mice via Insulin-Like Growth Factor-Binding Protein 5-Mediated Endoplasmic Reticulum Stress Modulation.
    Lee Y; Shin SH; Cho KA; Kim YH; Woo SY; Kim HS; Jung SC; Jo I; Jun HS; Park WJ; Park JW; Ryu KH
    Cells; 2019 Apr; 8(4):. PubMed ID: 31018536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRP78 overproduction in pancreatic beta cells protects against high-fat-diet-induced diabetes in mice.
    Teodoro-Morrison T; Schuiki I; Zhang L; Belsham DD; Volchuk A
    Diabetologia; 2013 May; 56(5):1057-67. PubMed ID: 23475366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice.
    Li JM; Li X; Chan LWC; Hu R; Zheng T; Li H; Yang S
    Diabetologia; 2023 Dec; 66(12):2368-2386. PubMed ID: 37615690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle miR-16 deletion results in impaired insulin sensitivity and contractile function in a sex-dependent manner.
    Lim S; Deaver JW; Rosa-Caldwell ME; Lee DE; Morena da Silva F; Cabrera AR; Schrems ER; Saling LW; Washington TA; Fluckey JD; Greene NP
    Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E278-E292. PubMed ID: 35068192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes.
    Latouche C; Natoli A; Reddy-Luthmoodoo M; Heywood SE; Armitage JA; Kingwell BA
    PLoS One; 2016; 11(5):e0155108. PubMed ID: 27163678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice.
    Ying W; Gao H; Dos Reis FCG; Bandyopadhyay G; Ofrecio JM; Luo Z; Ji Y; Jin Z; Ly C; Olefsky JM
    Cell Metab; 2021 Apr; 33(4):781-790.e5. PubMed ID: 33450179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes.
    Nesca V; Guay C; Jacovetti C; Menoud V; Peyot ML; Laybutt DR; Prentki M; Regazzi R
    Diabetologia; 2013 Oct; 56(10):2203-12. PubMed ID: 23842730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.